StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$121.16+3.09 (+2.62%)

Close on Nov 13, 2026Market cap $26.58BP/E –Yield –

Insmed gross margin

Gross margin is gross profit as a percentage of revenue.

Insmed's gross margin for the twelve months ending Sep 30, 2026 was 84.4%. For fiscal 2025 it was 79.7%, against 76.4% the year before. The highest annual figure on record is 82.3% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202579.7%+3.3
FY2024Dec 31, 202476.4%−2.1
FY2023Dec 31, 202378.5%+1.0
FY2022Dec 31, 202277.5%+1.0
FY2021Dec 31, 202176.6%+0.8
FY2020Dec 31, 202075.7%−6.5
FY2019Dec 31, 201982.3%+6.9
FY2018Dec 31, 201875.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202685.1%+5.7
Q2 FY2026Jun 30, 202684.2%+10.3
Q1 FY2026Mar 31, 202684.5%+7.4
Q4 FY2025Dec 31, 202583.2%+8.3
Q3 FY2025Sep 30, 202579.4%+2.0
Q2 FY2025Jun 30, 202573.9%−2.9
Q1 FY2025Mar 31, 202577.1%+0.2
Q4 FY2024Dec 31, 202475.0%−3.0
Q3 FY2024Sep 30, 202477.3%−1.5
Q2 FY2024Jun 30, 202476.8%−1.7
Q1 FY2024Mar 31, 202476.9%−1.9
Q4 FY2023Dec 31, 202378.0%+0.0
Q3 FY2023Sep 30, 202378.9%−1.2
Q2 FY2023Jun 30, 202378.5%+3.7
Q1 FY2023Mar 31, 202378.8%+1.7
Q4 FY2022Dec 31, 202278.0%+1.6
Q3 FY2022Sep 30, 202280.1%+1.9
Q2 FY2022Jun 30, 202274.9%−1.2
Q1 FY2022Mar 31, 202277.0%+1.5
Q4 FY2021Dec 31, 202176.3%+2.6
Q3 FY2021Sep 30, 202178.2%+2.6
Q2 FY2021Jun 30, 202176.1%−0.5
Q1 FY2021Mar 31, 202175.5%−1.6
Q4 FY2020Dec 31, 202073.8%−7.2
Q3 FY2020Sep 30, 202075.7%−7.8
Q2 FY2020Jun 30, 202076.6%−7.0
Q1 FY2020Mar 31, 202077.1%−3.9
Q4 FY2019Dec 31, 201981.0%+5.6
Q3 FY2019Sep 30, 201983.4%–
Q2 FY2019Jun 30, 201983.6%–
Q1 FY2019Mar 31, 201981.1%–
Q4 FY2018Dec 31, 201875.4%–

More Insmed figures

See a number that looks wrong?